WellTheory, a digital well being firm for autoimmune illness, announced on Tuesday that it has raised $14 million in Collection A funding, which is able to assist the corporate scale and advance its AI.
Atherton, California-based WellTheory treats autoimmune circumstances equivalent to Addison’s illness, celiac illness, a number of sclerosis and lupus. Utilizing a collaborative care mannequin, it companions with sufferers’ physicians to ship personalised plans targeted on diet, stress, sleep and motion. The corporate presents video classes, limitless skilled messaging and diagnostics. It serves each employers and well being plans.
The Collection A spherical was led by Common Catalyst and included participation from 7wireVentures, Ingeborg Investments, Accel, Field Group, Leaps by Bayer and Up2 Alternative Fund. In whole, WellTheory has raised $26.2 million.
“WellTheory is addressing the impression of autoimmune illness by recognizing the necessary function that weight-reduction plan and way of life can play in supporting sufferers. The platform is demonstrating how this sort of assist could be delivered at scale, and that is just the start. It’s increasing to combine medical remedy and medicine administration, making a extra complete mannequin designed to enhance affected person experiences and strengthen system sustainability,” mentioned Candace Richardson, companion at Common Catalyst, in an announcement. Richardson is becoming a member of WellTheory’s board.
The financing will assist increase Welltheory’s partnerships with new and current prospects, in response to Ellen Rudolph, CEO and co-founder of WellTheory.
“We’ll be increasing our applications for among the most expensive autoimmune circumstances and accelerating the event of our AI capabilities,” she added in an electronic mail. “These efforts will assist us ship whole-person autoimmune care at scale — bettering high quality of life for our members whereas driving vital price financial savings for our companions.”
Since launching within the business market about 18 months in the past, WellTheory has secured a number of main employer shoppers, together with Dayforce, Fortune Manufacturers Improvements and Maven Clinic. It additionally introduced in June that it’s working with Sentara Well being Plans.
The funding announcement comes at a time when greater than 50 million Individuals battle autoimmune circumstances, together with rheumatoid arthritis, lupus and a number of sclerosis. The autoimmune remedy market is increasing quickly, valued at greater than $166 billion in 2024.
WellTheory finally goals to scale to satisfy this demand, in response to Rudolph.
“We’re getting into our subsequent section of development, targeted on increasing entry to our mannequin by means of new employer and payor partnerships, investing in AI that permits extra exact and compassionate care, and persevering with to construct proof for our outcomes. … Our north star stays the identical: making high-quality, whole-person look after autoimmune illness accessible, reasonably priced, and sustainable for sufferers and the healthcare system alike,” she mentioned.
Image: Feodora Chiosea, Getty Photographs
